David Jacquier

Lausanne University Hospital

Switzerland

Research Interests

Explore related searches

Professors in Switzerland Professors in Immunology Immunology professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (9)

Year:

2025

Year:

2025

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (3)

Christoph Neuwirth

Deputy Head

Kantonsspital St. Gallen

SWITZERLAND

View details

Olivier Scheidegger

SWITZERLAND

View details

Diana Ballhausen

Head of pediatric metabolic unit

Lausanne University Hospital

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

David Jacquier

Research Interests

Explore related searches

Contact this professor

Articles (9)

Real-world data on the effect of long-term treatment with nusinersen over > 4 years in a cohort of Swiss patients with spinal muscular atrophy

Structural and Functional Characterization of N-Glycanase-1 Pathogenic Variants

Treatment of spinal muscular atrophy with Onasemnogene Abeparvovec in Switzerland: a prospective observational case series study

Evaluation of real-life outcome data of patients with spinal muscular atrophy treated with nusinersen in Switzerland

Rituximab in juvenile myasthenia gravis-an international cohort study and literature review

Comprendre, évaluer et traiter la douleur de l’enfant en situation de polyhandicap

Amyotrophie spinale: une mise à jour

Spinale Muskelatrophie - ein Update

Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go

Collaborators (3)

Christoph Neuwirth

Olivier Scheidegger

Diana Ballhausen

Make your next move.

David Jacquier

Research Interests

Explore related searches

Contact this professor

Articles (9)

Real-world data on the effect of long-term treatment with nusinersen over > 4 years in a cohort of Swiss patients with spinal muscular atrophy

Structural and Functional Characterization of N-Glycanase-1 Pathogenic Variants

Treatment of spinal muscular atrophy with Onasemnogene Abeparvovec in Switzerland: a prospective observational case series study

Evaluation of real-life outcome data of patients with spinal muscular atrophy treated with nusinersen in Switzerland

Rituximab in juvenile myasthenia gravis-an international cohort study and literature review

Comprendre, évaluer et traiter la douleur de l’enfant en situation de polyhandicap

Amyotrophie spinale: une mise à jour

Spinale Muskelatrophie - ein Update

Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go

Collaborators (3)

Christoph Neuwirth

Olivier Scheidegger

Diana Ballhausen

Make your next move.

Real-world data on the effect of long-term treatment with nusinersen over > 4 years in a cohort of Swiss patients with spinal muscular atrophy